AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Clinical trial NCT04062266 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04062266
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia in Remission FLT3 Gene Mutation Hematologic and Lymphocytic Disorder Acute Myeloid Leukemia Minimal Residual Disease Persistence Therapy-Related Acute Myeloid Leukemia

Start date: 2019-09-13
Primary completion: 2030-10-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.